Novo Nordisk
NVO
#24
Rank
NZ$686.77 B
Marketcap
$152.18
Share price
-0.99%
Change (1 day)
-28.40%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): NZ$31.55 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are NZ$41.89 Billion. , an increase over its 2023 earnings that were of NZ$26.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 NZ$33.06 B22.75%
2023 NZ$26.93 B57.64%
2022 NZ$17.08 B5.35%
2021 NZ$16.22 B12.47%
2020 NZ$14.42 B13.07%
2019 NZ$12.75 B-3.35%
2018 NZ$13.19 B1.79%
2017 NZ$12.96 B4.52%
2016 NZ$12.40 B9.42%
2015 NZ$11.33 B8.24%
2014 NZ$10.47 B3.45%
2013 NZ$10.12 B19.02%
2012 NZ$8.50 B15.21%
2011 NZ$7.38 B17.71%
2010 NZ$6.27 B24.78%
2009 NZ$5.02 B10.62%
2008 NZ$4.54 B55.97%
2007 NZ$2.91 B7.07%
2006 NZ$2.72 B18.18%
2005 NZ$2.30 B11.33%
2004 NZ$2.06 B
2002 NZ$1.33 B-14.39%
2001 NZ$1.55 B-52.82%
2000 NZ$3.29 B250%
1999 NZ$0.94 B31.21%
1998 NZ$0.71 B34.31%
1997 NZ$0.53 B11.46%
1996 NZ$0.47 B9.03%
1995 NZ$0.43 B-3.15%
1994 NZ$0.45 B-0.67%
1993 NZ$0.45 B45.38%
1992 NZ$0.31 B-13.81%
1991 NZ$0.36 B37.12%
1990 NZ$0.26 B-0.79%
1989 NZ$0.26 B26.2%
1988 NZ$0.21 B24.97%
1987 NZ$0.16 B-0.9%
1986 NZ$0.17 B-7.78%
1985 NZ$0.18 B24.87%
1984 NZ$0.14 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$12.12 B-63.34%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.13 B-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.63 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.86 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France